Stock Analysis·← Pickers

PRENW

Prenetics Global Limited

Prenetics Global Limited (PRENW) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 52.0, with 1/3 trend checks passing.

Price
$0.02
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
52.0
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

PRENW with MA50 and MA200

0.040.040.030.020.0106/0409/1612/2904/1407/15
PRENW2025-06-042026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$0.02+2.68% vs price
MA200
$0.02-21.93% vs price
RSI (14)
52.0Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
$0.02–$0.025.7% below price · 2 touches
Support Quality
2 touches1.4× zone volume
Chart Summary
Trend summary for PRENW

Prenetics Global Limited (PRENW) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $0.02, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 2.7% and below the 200-day moving average by 21.9%.

Momentum and stretch context

PRENW currently has an RSI reading of 52.0, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

This page is designed to help you quickly understand what the PRENW chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Prenetics Global Limited

Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem. Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Sheng Wu Yeung
Employees
98
Market cap
$369.5M
Beta
0.25
52-week range
$0.02 – $0.02
Dividend
No
Exchange
NASDAQ
Country
HK
IPO date
16 Jul 2021
ISIN
KYG722451146
CUSIP
G72245114
Company profile data from Financial Modeling Prep. PRENW listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about PRENW

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.